Cargando…

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform

INTRODUCTION: Advanced gynecologic cancers have a poor prognosis and constitute a major challenge for adequate treatment strategies. By analyzing and targeting molecular alterations, molecular guided treatments may be a viable option for the treatment of advanced gynecologic cancers. PATIENTS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Aust, Stefanie, Polterauer, Stephan, Kölbl, Heinz, Seebacher, Veronika, Grimm, Christoph, Reinthaller, Alexander, Prager, Gerald W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356753/ https://www.ncbi.nlm.nih.gov/pubmed/32369643 http://dx.doi.org/10.1634/theoncologist.2019-0904

Ejemplares similares

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older
por: Reiser, Elisabeth, et al.
Publicado: (2020)

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2020)

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery
por: Bekos, Christine, et al.
Publicado: (2019)

Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
por: Grech, Christina T., et al.
Publicado: (2022)

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
por: Poetsch, Nina, et al.
Publicado: (2019)

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data
por: Oberndorfer, Felicitas, et al.
Publicado: (2021)

Molecularly guided treatment of metastatic parotid gland carcinoma in adults
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

An Intervention-Based Approach to Achieve Racial Equity in Gynecologic Oncology
por: Gamble, Charlotte, et al.
Publicado: (2023)

Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors
por: Taghizadeh, Hossein, et al.
Publicado: (2022)

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
por: Sultova, Elena, et al.
Publicado: (2020)

Obesity in Gynecologic Oncology
por: Kölbl, Heinz, et al.
Publicado: (2020)

Applied precision cancer medicine in metastatic biliary tract cancer
por: Taghizadeh, H., et al.
Publicado: (2020)

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology
por: Prager, Gerald W., et al.
Publicado: (2019)

Applied Precision Cancer Medicine in Neuro-Oncology
por: Taghizadeh, H., et al.
Publicado: (2019)

Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen
por: Seebacher, Veronika, et al.
Publicado: (2017)

Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
por: Kieler, Markus, et al.
Publicado: (2019)

Indirect effects of COVID-19 in referring women to gynecologic oncology, perinatology and gynecology clinics in Iran
por: Khazaeipour, Zahra, et al.
Publicado: (2021)

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
por: Seebacher, Veronika, et al.
Publicado: (2017)

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients
por: Bartl, Thomas, et al.
Publicado: (2021)

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study
por: Seebacher, Veronika, et al.
Publicado: (2018)

The prognostic value of four interleukin-1 gene polymorphisms in caucasian women with breast cancer – a multicenter study
por: Grimm, Christoph, et al.
Publicado: (2009)

Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Enhanced Recovery After Surgery Protocols in Obese Gynecological Oncology Patients: A Single-Center Experience
por: Pandraklakis, Anastasios, et al.
Publicado: (2023)

The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study
por: Seebacher, Veronika, et al.
Publicado: (2009)

Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
por: Loehberg, Christian R., et al.
Publicado: (2020)

Prognostic value of serum creatine level in patients with vulvar cancer
por: Schwameis, Richard, et al.
Publicado: (2019)

Influence of training level on cervical cone size and resection margin status at conization: a retrospective study
por: Montanari, Eliana, et al.
Publicado: (2018)

Closed-Incision Negative Pressure Wound management Following Midline Laparotomy in Gynecological Oncology Operations: A Feasibility Pilot Study
por: Yin, Lucia, et al.
Publicado: (2021)

The impact of lymph node density on survival of cervical cancer patients
por: Polterauer, S, et al.
Publicado: (2010)

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial
por: Grimm, Christoph, et al.
Publicado: (2014)

Students’ attitudes toward digital learning during the COVID-19 pandemic: a survey conducted following an online course in gynecology and obstetrics
por: Olmes, Gregor Leonhard, et al.
Publicado: (2021)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany
por: Kaltofen, Till, et al.
Publicado: (2021)

Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany
por: Grimm, Donata, et al.
Publicado: (2020)

Recommendations by the gynecologic endoscopy working group of the german society of obstetrics and gynecology for the advancement of training and education in minimal-access surgery
por: De Wilde, Rudy Leon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_er0h84ebbfs2cn6v6399hlkpon